OPKO Health, Inc. Line of Credit, Current
OPKO Health, Inc. (OPK) had Line of Credit, Current of $24.37 million as of 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2023-05-03
- 2023-03-31: Line of Credit, Current $24.37M.
- 2022-12-31: Line of Credit, Current $33.54M.
- 2022-09-30: Line of Credit, Current $23.34M.
- 2022-06-30: Line of Credit, Current $18.99M.
| Period end | Line of Credit, Current | Line of Credit, Current as first filed |
|---|---|---|
| 2023-03-31 | $24.37M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $33.54M 10-Q · filed 2023-05-03 | |
| 2022-09-30 | $23.34M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $18.99M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $17.41M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $14.70M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $14.89M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $17.96M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $17.82M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $24.70M 10-Q · filed 2021-10-28 | |
| 2020-09-30 | $12.70M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $14.46M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $12.80M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $9.62M 10-Q · filed 2020-10-29 | |
| 2019-09-30 | $7.19M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $11.24M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $112.32M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $5.85M 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $6.35M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $6.46M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.97M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $11.93M 10-Q · filed 2018-11-09 | |
| 2013-06-30 | $13.26M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $16.82M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $15.20M 10-Q · filed 2013-08-09 | $17.53M 10-K · filed 2013-03-18 |
| 2012-09-30 | $17.41M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $14.57M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $8.76M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $12.55M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $14.60M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $14.69M 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |